ALS AWARENESS MONTH

Illinois General Assembly - Full Text of SR0691

Select Language

×

The Illinois General Assembly offers the Google Translate™ service for visitor convenience. In no way should it be considered accurate as to the translation of any content herein.

Visitors of the Illinois General Assembly website are encouraged to use other translation services available on the internet.

The English language version is always the official and authoritative version of this website.

NOTE: To return to the original English language version, select the "Show Original" button on the Google Translate™ menu bar at the top of the window.

Choose Language

English

Afrikaans

Albanian

Arabic

Armenian

Azerbaijani

Basque

Bengali

Bosnian

Catalan

Croatian

Czech

Danish

Dutch

Esperanto

Estonian

Filipino

Finnish

French

Galician

Georgian

German

Greek

Gujarati

Haitian Creole

Hausa

Hawaiian

Hebrew

Hindi

Hungarian

Icelandic

Indonesian

Interlingua

Interlingue

Inuktitut

Irish

Italian

Japanese

Javanese

Kannada

Khmer

Korean

Latin

Latvian

Lithuanian

Luxembourgish

Macedonian

Malagasy

Malayalam

Maltese

Maori

Marathi

Myanmar

Nepali

Norwegian

Odia

Pashto

Punjabi

Romanian

Russian

Samoan

Sango

Sanskrit

Sardinian

Sindhi

Sinhala

Slovak

Slovenian

Somali

Southern Sotho

Spanish

Sundanese

Swahili

Swedish

Tamil

Telugu

Thai

Tigrinya

Tonga

Turkish

Ukrainian

Urdu

Vietnamese

Welsh

Xhosa

Yiddish

Yoruba

Zulu

Powered by
Translate

Close

Illinois General Assembly

Top Navigation Bar

Translate

Learn

Select General Assembly

Search the 104th General Assembly

Enter search terms for legislation, members, committees, or schedules.

ILGA.GOV

LEGISLATION & LAWS

Bills & Resolutions

Public Acts

Illinois Compiled Statutes

Illinois Constitution

Search Legislation

Glossary

Guide

Reports & Inquiry

Legislative Reports

Special Reports

FTP Site

Legislator Lookup

Capitol Complex Phone Numbers

Rules & Regulations

Illinois Register

Administrative Rules

Senate

Members

Schedules

Committees

Request for Remote Testimony

Journals

Transcripts

Rules

Audio/Video

FOIA Information

Senate Employment Opportunities

Media Guidelines

House

Members

Schedules

Committees

Submit testimony for House Committees

Journals

Transcripts

Rules

Audio/Video

FOIA Information

House Employment Opportunities

Log In

Mobile Top Bar

Search the 104th General Assembly

Enter keywords to search the Illinois General Assembly website.

Full Text of SR0691

Home

Legislation

Full Text

SR0691 - 104th General Assembly

Bill Status

Full Text

Votes

Witness Slips

Select Menu

Bill Status

Full Text

Votes

Witness Slips

Printer Friendly Version

Introduced

Printer Friendly Version

Introduced

Open PDF

SR0691
LRB104 21245 LAW 35888 r
1
SENATE RESOLUTION

2

WHEREAS, Amyotrophic lateral sclerosis (ALS), also
3
commonly known as Lou Gehrig's disease, is a progressive fatal
4
neurodegenerative disease in which a person's brain loses
5
connection with their muscles, slowly reducing a person's
6
ability to walk, talk, eat, and eventually breathe; and

7

WHEREAS, Thousands of new ALS cases are reported every
8
year, and estimates show that someone is diagnosed with ALS
9
and someone passes away from ALS every 90 minutes; and

10

WHEREAS, On average, patients diagnosed with ALS survive
11
only two to five years from the time of diagnosis; and

12

WHEREAS, The exact causes of ALS are unknown, and there is
13
no known cure for ALS; and

14

WHEREAS, People who have served in the military are more
15
likely to develop ALS and die from the disease than those with
16
no history of military service; and

17

WHEREAS, Securing access to new therapies, durable medical
18
equipment, and communication technologies is of vital
19
importance to people living with ALS; and

SR0691
- 2 -
LRB104 21245 LAW 35888 r
1

WHEREAS, Clinical trials play a pivotal role in evaluating
2
new treatments, enhancing quality of life, and fostering
3
assistive technologies for those living with ALS; and

4

WHEREAS, The ALS Association is the largest philanthropic
5
funder of ALS research globally and has committed more than
6
$154 million to support more than 550 projects across the
7
United States and 18 other countries; and

8

WHEREAS, The ALS Association is committed to making ALS
9
livable and curing it for everyone, everywhere; and

10

WHEREAS, Observing ALS Awareness Month increases public
11
awareness of the dire circumstances of people living with ALS,
12
acknowledges the terrible impact this disease has on those
13
individuals and their families, and supports research being
14
done to eradicate this disease; therefore, be it

15

RESOLVED, BY THE SENATE OF THE ONE HUNDRED FOURTH GENERAL
16
ASSEMBLY OF THE STATE OF ILLINOIS, that we declare May 2026 as
17
ALS Awareness Month in the State of Illinois, and we urge all
18
Illinoisans to engage in supporting amyotrophic lateral
19
sclerosis (ALS) research, advocating for increased funding,
20
and standing in solidarity with those affected by this
21
relentless disease.

Footer

Disclaimer

This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.

Contact ILGA Webmaster

ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies

ILGA.GOV

2026 ILGA.gov | All Rights Reserved |
ADA

|
Disclaimers
|
Learn

This site is maintained for the Illinois General Assembly by the
Legislative Information System, 705 Stratton Building, Springfield, Illinois 62706.
Contact ILGA Webmaster

ILGA.gov uses cookies to ensure you get the best experience on our website. By continuing to browse ILGA.gov you consent to our use of cookies.
Read About Cookies

ILGA.GOV

2026 ILGA.gov | All Rights Reserved |
ADA

|
Disclaimers
|
Learn